The Investor Using Venture Capital and Machine Learning to Cure Cancer

Vijay Pande, a lifelong coder who holds a couple of degrees in physics, doesn’t seem like he’d be the guy to thwart death. But Pande, a general partner at the venture firm Andreessen Horowitz since 2015, is providing money muscle to computer-powered medical startups including BioAge Labs , which uses genomics data to create anti-aging drugs, and Asimov, which is programming cells to fight disease. (Bloomberg LP, which owns Bloomberg Businessweek , is an investor in Andreessen Horowitz.) One of Pande’s first investments, Freenome Inc. , uses machine learning to help detect cancer in its earliest stages by reading signals sent by the immune system.

Source: The Investor Using Venture Capital and Machine Learning to Cure Cancer